標(biāo)題: Titlebook: Atlas of Hypertension; Norman K. Hollenberg (Professor of Radiology, Dire Book 2003Latest edition Springer Science+Business Media New York [打印本頁(yè)] 作者: papertrans 時(shí)間: 2025-3-21 19:43
書(shū)目名稱Atlas of Hypertension影響因子(影響力)
書(shū)目名稱Atlas of Hypertension影響因子(影響力)學(xué)科排名
書(shū)目名稱Atlas of Hypertension網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Atlas of Hypertension網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Atlas of Hypertension被引頻次
書(shū)目名稱Atlas of Hypertension被引頻次學(xué)科排名
書(shū)目名稱Atlas of Hypertension年度引用
書(shū)目名稱Atlas of Hypertension年度引用學(xué)科排名
書(shū)目名稱Atlas of Hypertension讀者反饋
書(shū)目名稱Atlas of Hypertension讀者反饋學(xué)科排名
作者: 人充滿活力 時(shí)間: 2025-3-21 23:00 作者: Innocence 時(shí)間: 2025-3-22 03:25
Die renale Ganzkorperclearance,iety, the emphasis is on targeting effective single-drug, low-cost therapy for patients who are at the highest risk. We have progressed only a little in this regard. We do not yet have sophisticated markers of enzyme and receptor genotypes, which may someday increase our specificity of whom we treat作者: capsule 時(shí)間: 2025-3-22 07:49
https://doi.org/10.1007/3-540-28884-8ferent arteriole vasoconstricts during states of diminished effective arterial blood volume in order to maintain the glomerular capillary pressures necessary for ultrafiltration. With injury of the afferent arteriole, the glomerulus becomes more vulnerable to the effects of systemic BP due to inadeq作者: LATER 時(shí)間: 2025-3-22 11:47
Pathogenesis of Hypertension: Vascular Mechanisms,ponse to an elevated intravascular pressure perpetuate and probably worsen the hypertension. Significant new insights have been developed into both functional and structural changes that may contribute to the initiation and/or progression of this condition.作者: ICLE 時(shí)間: 2025-3-22 14:04 作者: 使絕緣 時(shí)間: 2025-3-22 19:42
Antihypertensive therapy: Progression of Renal Injury,ferent arteriole vasoconstricts during states of diminished effective arterial blood volume in order to maintain the glomerular capillary pressures necessary for ultrafiltration. With injury of the afferent arteriole, the glomerulus becomes more vulnerable to the effects of systemic BP due to inadeq作者: Fresco 時(shí)間: 2025-3-22 23:11 作者: 有害處 時(shí)間: 2025-3-23 02:40 作者: PRE 時(shí)間: 2025-3-23 07:15
Antihypertensive Agents: Mechanisms of Drug Action,dence of stroke and coronary events [1]. Even modest elevations in blood pressure (both systolic and diastolic) are associated with an increased health risk. Hypertension also predisposes to left ventricular hypertrophy and chronic renal failure [2,3].作者: 符合你規(guī)定 時(shí)間: 2025-3-23 12:14 作者: Accede 時(shí)間: 2025-3-23 15:50 作者: interrupt 時(shí)間: 2025-3-23 21:52
https://doi.org/10.1007/978-3-642-65092-5though the existence of the renin-angiotensin system has been known for over two decades, recent advances in cell and molecular biology as well as renal physiology have opened the doors for a greater understanding of the role of this system in normal and disease states. Exciting new concepts, such a作者: Annotate 時(shí)間: 2025-3-23 23:36
A. Everette James Jr.,S. Boyd Eaton Jr.muli of vascular constriction and on endocrine and renal stimuli that control blood volume. It has become clear that strong environmental and genetic influences converge to result in the hypertensive phenotype [1]. With the development of the science of vascular biology in recent years there has bee作者: exceed 時(shí)間: 2025-3-24 06:17 作者: 愚笨 時(shí)間: 2025-3-24 07:47 作者: debouch 時(shí)間: 2025-3-24 12:00 作者: Jubilation 時(shí)間: 2025-3-24 17:55 作者: Ringworm 時(shí)間: 2025-3-24 20:41
Die renale Ganzkorperclearance,ease. Hypertension, whether systolic, diastolic, or isolated systolic, is a major risk factor for vascular and target organ damage. Increased systolic blood pressure, increased pulse rate, and high baseline heart rate are definite cardiovascular risk factors. Recent data support the concept that eve作者: 靈敏 時(shí)間: 2025-3-25 02:56
https://doi.org/10.1007/3-540-28884-8rtery disease and renal disease have not been prevented [1,2]. Our ability to prevent hypertensive nephropathy through traditional methods of lowering BP may not be as effective as once thought, particularly in high-risk patients [3–6]. One reason for this may be our inability to adequately control 作者: 陶器 時(shí)間: 2025-3-25 05:38
Stephen Arnold,Mayumi Noto,Frank Vollmerion from functioning in these roles. A comprehensive and universal definition of QOL is difficult to achieve, probably because the precise elements for evaluating QOL vary under different circumstances and in different individuals. Furthermore, the definition of a “good” QOL may vary depending on th作者: 睨視 時(shí)間: 2025-3-25 08:48 作者: Coronation 時(shí)間: 2025-3-25 12:05 作者: 帶傷害 時(shí)間: 2025-3-25 19:07 作者: 聯(lián)想 時(shí)間: 2025-3-25 22:26 作者: progestogen 時(shí)間: 2025-3-26 02:00
Springer Science+Business Media New York 2003作者: gastritis 時(shí)間: 2025-3-26 05:11
Die renale Ganzkorperclearance,dence of stroke and coronary events [1]. Even modest elevations in blood pressure (both systolic and diastolic) are associated with an increased health risk. Hypertension also predisposes to left ventricular hypertrophy and chronic renal failure [2,3].作者: arabesque 時(shí)間: 2025-3-26 09:55 作者: 有花 時(shí)間: 2025-3-26 16:13
“Physics as Meaning Circuit”: Three ProblemsLike obesity and diabetes, essential hypertension is one of the “diseases of civilization” that results from the collision of a modern lifestyle with Paleolithic genes.作者: ovation 時(shí)間: 2025-3-26 18:04
General , Factory Design Considerations,This chapter reviews the guidelines for accurate and reliable blood pressure (BP) measurement and quality assurance methods that must be implemented in the day-to-day practice of medicine if the proven benefits of detecting and treating high BP are to be translated to the population.作者: 因無(wú)茶而冷淡 時(shí)間: 2025-3-27 00:17
Pathogenesis of Hypertension: Genetic and Environmental Factors,Like obesity and diabetes, essential hypertension is one of the “diseases of civilization” that results from the collision of a modern lifestyle with Paleolithic genes.作者: 出沒(méi) 時(shí)間: 2025-3-27 03:17 作者: GENUS 時(shí)間: 2025-3-27 06:55 作者: Pedagogy 時(shí)間: 2025-3-27 12:49
Kidney, Sodium, and the Renin-Angiotensin System,though the existence of the renin-angiotensin system has been known for over two decades, recent advances in cell and molecular biology as well as renal physiology have opened the doors for a greater understanding of the role of this system in normal and disease states. Exciting new concepts, such a作者: 抵押貸款 時(shí)間: 2025-3-27 15:37 作者: 膝蓋 時(shí)間: 2025-3-27 18:14 作者: Harbor 時(shí)間: 2025-3-28 00:12
Secondary Hypertension: Adrenal and Nervous Systems,entage of individuals with so-called . ranges from more than 5% of all hypertensive patients presenting in a community clinical practice to more than 30% in referral centers. It is especially important to identify patients with secondary hypertension because correction of the cause will often cure—n作者: Extemporize 時(shí)間: 2025-3-28 02:25
Antihypertensive Agents: Mechanisms of Drug Action,dence of stroke and coronary events [1]. Even modest elevations in blood pressure (both systolic and diastolic) are associated with an increased health risk. Hypertension also predisposes to left ventricular hypertrophy and chronic renal failure [2,3].作者: aqueduct 時(shí)間: 2025-3-28 06:49 作者: Magisterial 時(shí)間: 2025-3-28 12:32
Antihypertensive Therapy: Patient Selection and Special Problems,ease. Hypertension, whether systolic, diastolic, or isolated systolic, is a major risk factor for vascular and target organ damage. Increased systolic blood pressure, increased pulse rate, and high baseline heart rate are definite cardiovascular risk factors. Recent data support the concept that eve作者: 翻布尋找 時(shí)間: 2025-3-28 17:35
Antihypertensive therapy: Progression of Renal Injury,rtery disease and renal disease have not been prevented [1,2]. Our ability to prevent hypertensive nephropathy through traditional methods of lowering BP may not be as effective as once thought, particularly in high-risk patients [3–6]. One reason for this may be our inability to adequately control 作者: 慌張 時(shí)間: 2025-3-28 18:55 作者: FACET 時(shí)間: 2025-3-29 01:20 作者: 停止償付 時(shí)間: 2025-3-29 03:45 作者: FANG 時(shí)間: 2025-3-29 08:23 作者: 有效 時(shí)間: 2025-3-29 11:30 作者: Dissonance 時(shí)間: 2025-3-29 15:39
Iteration and accelerator dynamics,tensive emergencies), or when BP measurement is accomplished using techniques other than the indirect sphygmomanometric determinations in the physician’s office. This chapter attempts to address some of these special situations.作者: 退出可食用 時(shí)間: 2025-3-29 20:16
Kidney, Sodium, and the Renin-Angiotensin System,t studies. New angiotensin peptides with unique actions have been identified, and the role of angiotensins as cell-to-cell mediators . paracrine substances) in the kidney has recently been appreciated.作者: Senescent 時(shí)間: 2025-3-30 00:29 作者: intricacy 時(shí)間: 2025-3-30 05:31 作者: 矛盾心理 時(shí)間: 2025-3-30 11:39 作者: epicardium 時(shí)間: 2025-3-30 16:06
Antihypertensive Therapy: Compliance and Quality of Life,r evaluating QOL vary under different circumstances and in different individuals. Furthermore, the definition of a “good” QOL may vary depending on the culture, age, gender, and personal preference of the individual.作者: GLOSS 時(shí)間: 2025-3-30 17:07 作者: CLEAR 時(shí)間: 2025-3-31 00:02 作者: CLAP 時(shí)間: 2025-3-31 02:22 作者: 蹣跚 時(shí)間: 2025-3-31 07:16
Role of the Nervous System in Human Hypertension,eals with the complexities involved in the evaluation of autonomic function in humans, and the second is that hypertension is a dynamic process in which the manifestations of autonomic overactivity change with time.作者: 印第安人 時(shí)間: 2025-3-31 10:42
Cardiovascular Risk Assessment in Hypertension,ptably high. Hypertensive persons have significantly increased total and low-density lipoprotein (LDL) cholesterol, elevated triglycerides, and impaired glucose tolerance that augment the hazard of elevated blood pressure.作者: 江湖郎中 時(shí)間: 2025-3-31 13:51 作者: Scintillations 時(shí)間: 2025-3-31 20:16 作者: colostrum 時(shí)間: 2025-3-31 22:07
https://doi.org/10.1007/BFb0031487United States. The World Health Organization-International Society of Hypertension (WHO-ISH) Subcommittee [2] is selected by those two organizations and is largely European, although this committee report also reflects American and Canadian views, as well as views of two members of the Japanese Hypertension Society.
